Donor Clinical Trials

42 recruitingLast updated: July 25, 2026

There are 42 actively recruiting donor clinical trials across 20 countries. Studies span Not Applicable, Phase 2, Phase 3, Early Phase 1, Phase 1. Top locations include Bethesda, Maryland, United States, Hangzhou, Zhejiang, China, Antwerp, Belgium. Updated daily from ClinicalTrials.gov.


Donor Trials at a Glance

42 actively recruiting trials for donor are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 19 trials, with the heaviest enrollment activity in Bethesda, Hangzhou, and Antwerp. Lead sponsors running donor studies include Apellis Pharmaceuticals, Inc., BioCytics, Inc., and AUSL Romagna Rimini.

Browse donor trials by phase

Treatments under study

About Donor Clinical Trials

Looking for clinical trials for Donor? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Donor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Donor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 42 trials

Recruiting

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Hematopoietic Stem Cell TransplantationTissue DonorsCellular Immunotherapy, Adoptive+1 more
National Cancer Institute (NCI)2,000 enrolled1 locationNCT03000244
Recruiting
Not Applicable

Magnetic Resonance Cholangiopancreatography in Living Liver Donors and Its Relationship With Post Operative Recipient Biliary Complications

Liver Transplant; ComplicationsChronic Liver Disease and CirrhosisDonor Hepatectomy
Institute of Liver and Biliary Sciences, India100 enrolled1 locationNCT07715500
Recruiting

Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use

Blood DonorsResearch SubjectsApheresis
National Institutes of Health Clinical Center (CC)5,000 enrolled1 locationNCT00001846
Recruiting
Phase 3

Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors

Healthy Hematopoietic Stem Cell DonorHealthy Allogeneic Hematopoietic Stem Cell Donor
First Affiliated Hospital of Zhejiang University560 enrolled8 locationsNCT07692841
Recruiting
Phase 1

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Living Donor Kidney Transplantation
Stanford University22 enrolled2 locationsNCT03943238
Recruiting
Not Applicable

Active Oxygen Gel Versus Hyaluronic Acid Gel for Palatal Wound Healing After Free Gingival Graft

Mucogingival DefectsPalatal Wound HealingFree Gingival Graft Donor Site
Suez Canal University30 enrolled1 locationNCT07683351
Recruiting

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI)500 enrolled1 locationNCT00001529
Recruiting
Not Applicable

Drain vs No Drain After Live Donor Hepatectomy

Donor Hepatectomy
Marengo Asia Hospitals80 enrolled1 locationNCT06769776
Recruiting
Not Applicable

Rectus-Intercostal Fascial Plane Block for Liver Transplantation Donors

Postoperative PainLiver TransplantationLiving Donor
Istinye University64 enrolled1 locationNCT07233096
Recruiting
Early Phase 1

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

LymphomaLeukemiaCAR-T Cell Therapy+3 more
University of Arizona200 enrolled1 locationNCT06643221
Recruiting
Not Applicable

Palatal Wound Healing After Free Gingival Graft Surgery

Gingival Recession, LocalizedPalatal Donor Site Wound Healingpostoperative morbidity
Kahramanmaras Sutcu Imam University55 enrolled1 locationNCT07409571
Recruiting
Not Applicable

Dietary Interventions During Living Kidney Donations

Living-Kidney Donors
University of Cologne80 enrolled1 locationNCT05709600
Recruiting
Not Applicable

Validation of Donor Oocytes Semi-automated Vitrification

FertilityVitrificationEgg Donor+1 more
University Hospital, Clermont-Ferrand50 enrolled1 locationNCT06238570
Recruiting

Endothelial Glycocalyx Damage in Brain Death Organ Donors

Brain Damage Due to HypoxiaOrgan DonorsOrgan Transplant Failure or Rejection
University Hospital Hradec Kralove100 enrolled1 locationNCT05609123
Recruiting
Not Applicable

Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients

Transplant DonationRenal TransplantationDonor Nephrectomy
Sakarya University40 enrolled1 locationNCT07533669
Recruiting
Early Phase 1

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Allogeneic Hematopoietic Stem Cell Transplantation RecipientAdenovirusCytomegalovirus+2 more
Sumithira Vasu20 enrolled2 locationsNCT03665675
Recruiting
Not Applicable

Blue Light for Donor Site Healing in Burn Patients

Donor Site ComplicationBurnPhotobiomodulation Therapy+1 more
AUSL Romagna Rimini25 enrolled1 locationNCT07453927
Recruiting

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Solid Tumor, AdultHealthy DonorsCOVID-19 Donors
BioCytics, Inc.1,500 enrolled1 locationNCT00571389
Recruiting

Single-center Evaluation of Human Milk Quantity and Quality Over Five Years

Lactating Women - Human Milk Donors
Charles University, Czech Republic500 enrolled1 locationNCT07309146
Recruiting
Phase 3

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

End Stage Renal DiseaseDelayed Graft FunctionDeceased Donor Kidney Transplant
Apellis Pharmaceuticals, Inc.320 enrolled1 locationNCT07020832